2008 Annual Meeting

Session: Reaction Engineering in Pharmaceuticals and Fine Chemicals

Presentations are solicited for reaction engineering in the development and scale-up of pharmaceutical and fine chemical processes. This work may include the integration of process analytical technology, modeling, and reactor design. Applications involving multiphase systems, mass transfer limited operations and novel reactor design on observed kinetic behavior is of particular interest to this session. Case studies that provide a better understanding of kinetics gained through process development are also encouraged to be submitted.

Chair

Thomas L. LaPorte, Bristol-Myers Squibb Company

Co-Chair

Mourad Hamedi, Merck and Co. Inc

Presentations

03:15 PM

Jale Müslehiddinoglu, Paul Lobben, Thomas Laporte, Lori Spangler, Daniel Fichana, Shih-Ying Chang, Donald Kientzler, Sushil Srivastava, John Venit, Robert Wethman, San Kiang

03:40 PM

04:05 PM

04:30 PM

04:55 PM

05:20 PM